181 related articles for article (PubMed ID: 34978646)
1. The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients.
Abbas EAER; Barakat AB; Hassany M; Youssef SS
J Genet Eng Biotechnol; 2022 Jan; 20(1):4. PubMed ID: 34978646
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
Youssef SS; El-Araby RE; Abbas EAE; Hassany M; Elbaz T
Expert Rev Mol Diagn; 2023 Mar; 23(3):267-278. PubMed ID: 36803362
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Mapping of Bcl9 Using Two Antibodies that Recognize Different Epitopes Is Useful to Characterize Juvenile Development of Hepatocellular Carcinoma in Myanmar.
Soe MT; Shibata Y; Win Htun M; Abe K; Soe K; Win Than N; Lwin T; Phone Kyaw M; Koji T
Acta Histochem Cytochem; 2019 Feb; 52(1):9-17. PubMed ID: 30923411
[TBL] [Abstract][Full Text] [Related]
4. Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma.
Huge N; Sandbothe M; Schröder AK; Stalke A; Eilers M; Schäffer V; Schlegelberger B; Illig T; Vajen B; Skawran B
Hepatol Int; 2020 May; 14(3):373-384. PubMed ID: 31440992
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial DNA Copy Number in Egyptian Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma.
Hashad DI; Elyamany AS; Salem PE
Genet Test Mol Biomarkers; 2015 Nov; 19(11):604-9. PubMed ID: 26447820
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma.
Xu W; Zhou W; Cheng M; Wang J; Liu Z; He S; Luo X; Huang W; Chen T; Yan W; Xiao J
Sci Rep; 2017 Jan; 7():40446. PubMed ID: 28074862
[TBL] [Abstract][Full Text] [Related]
7. Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma.
Ali LH; Higazi AM; Moness HM; Farag NM; Saad ZM; Moukareb HA; Soliman W; El Sagheer G; Abd El Hamid SR; Abdl Hamid H
Clin Exp Gastroenterol; 2019; 12():51-66. PubMed ID: 30774409
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
9. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.
Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
Korean J Pathol; 2013 Apr; 47(2):130-6. PubMed ID: 23667372
[TBL] [Abstract][Full Text] [Related]
11. Study of Toll-like Receptor 3 Gene Polymorphism as a Novel Risk Factor for HCV-related Hepatocellular Carcinoma in Egypt.
El-Sharawy S; Negm OE; Abd-Elsalam S; El-Sorogy HA; Shehata MAH
Curr Cancer Drug Targets; 2020; 20(5):382-389. PubMed ID: 32189594
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing.
Xu H; Zhu X; Xu Z; Hu Y; Bo S; Xing T; Zhu K
J Cancer; 2015; 6(3):247-53. PubMed ID: 25663942
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum alpha fetoprotein-L3 as an accuracy novel biomarker for the early diagnosis of hepatocellular carcinoma in Egyptian patients.
Ibrahim HM; Elghannam MZ; Elkhawaga OAY; El-Sokkary AMA
Saudi J Biol Sci; 2021 Oct; 28(10):5760-5764. PubMed ID: 34588888
[TBL] [Abstract][Full Text] [Related]
14. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Expression of Pygo2 Correlates with Poorly Differentiated State Involving c-Myc, PCNA and Bcl9 in Myanmar Hepatocellular Carcinoma.
Htun MW; Shibata Y; Soe K; Koji T
Acta Histochem Cytochem; 2021 Dec; 54(6):195-206. PubMed ID: 35023882
[TBL] [Abstract][Full Text] [Related]
17. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
18. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients.
Atta MM; Atta HM; Gad MA; Rashed LA; Said EM; Hassanien Sel-S; Kaseb AO
J Hepatocell Carcinoma; 2016; 3():19-24. PubMed ID: 27574588
[TBL] [Abstract][Full Text] [Related]
20. Characterization of fragment sizes, copy number aberrations and 4-mer end motifs in cell-free DNA of hepatocellular carcinoma for enhanced liquid biopsy-based cancer detection.
Jin C; Liu X; Zheng W; Su L; Liu Y; Guo X; Gu X; Li H; Xu B; Wang G; Yu J; Zhang Q; Bao D; Wan S; Xu F; Lai X; Liu J; Xing J
Mol Oncol; 2021 Sep; 15(9):2377-2389. PubMed ID: 34133846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
